Status:
UNKNOWN
Stopping Cardiovascular Treatments and Mortality in a MICU
Lead Sponsor:
University Hospital, Brest
Conditions:
Critical Care
Medication
Eligibility:
All Genders
15+ years
Brief Summary
Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted...
Detailed Description
Cardiovascular treatments should not be interrupted following hospital admission, in order to decrease patients' morbidity. However, following ICU admission, such treatments are frequently interrupted...
Eligibility Criteria
Inclusion
- All patients with cardiovascular treatment prior to ICU admission
Exclusion
- Data unavailability
- Consent withdrawal following information
Key Trial Info
Start Date :
May 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 2 2019
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04121429
Start Date
May 2 2019
End Date
November 2 2019
Last Update
October 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Intensive Care Unit, Brest University Hospital
Brest, France, 29200